Zobrazeno 1 - 10
of 104
pro vyhledávání: '"P. I. Lukienko"'
Publikováno v:
Bulletin of Experimental Biology and Medicine. 130:874-876
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 58(1)
Autor:
M I, Bushma, P I, Lukienko
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 57(5)
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 57(4)
Publikováno v:
Voprosy meditsinskoi khimii. 39(5)
Content of cytochromes P-450 and b5 and the rate of oxidative dealkylation in liver microsomes as well as the antipyrine pharmacokinetics were normalized in rats with acute CCl4-induced hepatitis after treatment with cordiamine (diethyl nicotinamide)
Publikováno v:
Voprosy meditsinskoi khimii. 39(3)
Methotrexate (N10-methyl-4-amino-4-deoxyfolic acid), administered to rats subcutaneously at a dose of 0.25 mg/kg within 14 days, was found to decrease content of microsomal protein in liver tissue and content of cytochromes P-450 and b5 as well as th
Publikováno v:
Farmakologiia i toksikologiia. 54(4)
Three and ten days after the administration of CCl4 (subcutaneously, once, 4 ml/kg of 50% oil solution) there were found a decrease of the rate of antipyrine elimination (intravenously, 50 mg/kg) from the blood plasma, an increase of the total biliru
Publikováno v:
Biulleten' eksperimental'noi biologii i meditsiny. 110(12)
The nicotinamide administration to rats (50 mg/kg, subcutaneously, over 5 days) increased the concentration of liver cytochrome b5, the activities of cytosol and microsomal glutathione S-transferase, UDP-glucuronosyltransferase and urinary excretion
Publikováno v:
Voprosy meditsinskoi khimii. 36(3)
Stimulation of lipid peroxidation, accompanied by a decrease in activity of UDP-glucuronyl- and glutathione-S-transferases, was observed in rat liver microsomes within one day after gamma-irradiation. Maximal alteration of the patterns studied was de
Publikováno v:
Farmakologiia i toksikologiia. 53(2)
Administration of diethylnicotinamide (250 mg orally three times for 8 days) to healthy subjects increased antipyrine (AP) elimination from the saliva by 23% and decreased its half-life by 26%. The excretion in the urine of the products of AP hydroxy